Paris, Ile-de-France, France The venture was found in Europe in France. The leading representative office of defined Corporate Investor is situated in the Paris.
We can highlight the next thriving fund investment areas, such as Pharmaceutical, Therapeutics. For fund there is a match between the location of its establishment and the land of its numerous investments - France. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. The fund has no specific favorite in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight TransCure bioServices, NH TherAguix.
The typical case for the fund is to invest in rounds with 2-3 participants. Despite the Arbevel, startups are often financed by Venture Kick, EASME - EU Executive Agency for SMEs. The meaningful sponsors for the fund in investment in the same round are Supernova Invest, Omnes Capital, Bpifrance.
The fund is constantly included in 2-6 deals per year. The usual things for fund are deals in the range of 5 - 10 millions dollars. The high activity for fund was in 2019.
Related Funds
| Fund Name | Location |
| Akilia Partners | - |
| Hefu Ruitai | - |
| Horus Capital | China, Qingdao Shi, Shandong |
| Inmarsat Plc | England, London, United Kingdom |
| Luna | - |
| Maoyan | Beijing, Beijing, China |
| Ningbo Shanshan | China, Ningbo, Zhejiang |
| Santo Venture Capital | Bayern, Germany, Holzkirchen |
| SF Capital Group | New York, New York, United States |
| Torreal | Madrid, Madrid, Spain |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
UroMems | $51M | 25 Jun 2024 | Grenoble, Auvergne-Rhône-Alpes, France | ||
MEXBRAIN | $6M | 06 May 2021 | Rhone-Alpes, Auvergne-Rhône-Alpes, France | ||
UroMems | $8M | 06 Apr 2021 | Grenoble, Auvergne-Rhône-Alpes, France | ||
Adwanted Group | $17M | 02 Apr 2021 | New York, New York, United States | ||
Corwave | $41M | 06 Jan 2021 | Paris, Ile-de-France, France | ||
keepMED | $15M | 29 Sep 2020 | North District | ||
UroMems | $18M | 20 May 2020 | France, Auvergne-Rhône-Alpes | ||
Scipio Bioscience | $7M | 25 Feb 2020 | Paris, Ile-de-France, France | ||
NH TherAguix | $15M | 11 Apr 2019 | Villeurbanne, Auvergne-Rhône-Alpes |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
UroMems | $51M | 25 Jun 2024 | Grenoble, Auvergne-Rhône-Alpes, France | ||
MEXBRAIN | $6M | 06 May 2021 | Rhone-Alpes, Auvergne-Rhône-Alpes, France | ||
UroMems | $8M | 06 Apr 2021 | Grenoble, Auvergne-Rhône-Alpes, France | ||
Adwanted Group | $17M | 02 Apr 2021 | New York, New York, United States | ||
Corwave | $41M | 06 Jan 2021 | Paris, Ile-de-France, France | ||
keepMED | $15M | 29 Sep 2020 | North District | ||
UroMems | $18M | 20 May 2020 | France, Auvergne-Rhône-Alpes | ||
Scipio Bioscience | $7M | 25 Feb 2020 | Paris, Ile-de-France, France | ||
NH TherAguix | $15M | 11 Apr 2019 | Villeurbanne, Auvergne-Rhône-Alpes |
